TSE:4568
TSE:4568Pharmaceuticals

Assessing Daiichi Sankyo Company (TSE:4568) Valuation After VANFLYTA Distribution Agreement With GENESIS Pharma

Why this VANFLYTA agreement matters for Daiichi Sankyo Company (TSE:4568) Daiichi Sankyo Company (TSE:4568) drew investor attention after signing an exclusive license and supply agreement with GENESIS Pharma to distribute and commercialize VANFLYTA across 13 Central and Eastern European markets. The deal extends access to quizartinib for adult patients with newly diagnosed FLT3 ITD positive acute myeloid leukemia, using GENESIS Pharma’s regional reach, while Daiichi Sankyo retains...
TSE:6758
TSE:6758Consumer Durables

A Look At Sony Group (TSE:6758) Valuation As PlayStation And Acquisition Concerns Resurface

Sony Group (TSE:6758) has completed a share buyback tranche, repurchasing 7,128,800 shares for ¥30,343.82 million, while fresh debate builds around the long term prospects of its PlayStation console business and recent acquisitions. See our latest analysis for Sony Group. Despite the recent buyback and noise around the PlayStation division and past acquisitions, Sony Group’s 1-month share price return of an 8.73% decline and 90-day share price return of an 11.90% decline contrast with a...
TSE:6301
TSE:6301Machinery

Komatsu (TSE:6301) Valuation Check After Recent Share Price Move And 40% Undervaluation Narrative

Komatsu (TSE:6301) is back on the radar after a recent share price move, with the stock closing at ¥5,127. For investors, that shift invites a closer look at returns and current valuation signals. See our latest analysis for Komatsu. That latest move comes after a mixed few months for the share price, with a 1-day share price return of 0.54% decline, a 7-day gain of 2.54% and a 90-day share price return of 3.72% decline. Longer term, total shareholder returns of 26.95% over 1 year and more...